| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.38▼ | 0.37▼ | 0.38▼ | 0.40▼ | 0.45▼ |
| MA10 | 0.38▼ | 0.38▼ | 0.38▼ | 0.42▼ | 0.45▼ |
| MA20 | 0.37▼ | 0.38▼ | 0.39▼ | 0.45▼ | 1.26▼ |
| MA50 | 0.38▼ | 0.40▼ | 0.41▼ | 0.45▼ | 1.70▼ |
| MA100 | 0.39▼ | 0.42▼ | 0.44▼ | 1.43▼ | 1.85▼ |
| MA200 | 0.40▼ | 0.45▼ | 0.46▼ | 1.71▼ | 1.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▼ | -0.001▼ | 0.001▲ | -0.062▼ |
| RSI | 45.335▼ | 36.652▼ | 34.932▼ | 32.972▼ | 30.367▼ |
| STOCH | 37.233 | 29.931 | 15.174▼ | 10.688▼ | 18.570▼ |
| WILL %R | -72.650 | -86.441▼ | -91.444▼ | -98.110▼ | -96.757▼ |
| CCI | 29.676 | -57.549 | -84.476 | -131.331▼ | -50.179 |
|
Thursday, June 04, 2026 05:54 AM
First-in-human Phase I study met its primary endpoint, demonstrating favourable safety and tolerability in healthy volunteers in the single ascending dose part of the studyPhase I data demonstrate ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/06/26 | 0.3885 | 0.3885 | 0.3701 | 0.3733 | 564,746 |
| 04/06/26 | 0.4075 | 0.4075 | 0.385 | 0.3886 | 837,255 |
| 03/06/26 | 0.415 | 0.415 | 0.3903 | 0.4067 | 706,579 |
| 02/06/26 | 0.4068 | 0.4234 | 0.40 | 0.416 | 1,524,271 |
| 01/06/26 | 0.433 | 0.4389 | 0.3923 | 0.3976 | 2,186,656 |
| 29/05/26 | 0.444 | 0.444 | 0.4256 | 0.4389 | 678,493 |
| 28/05/26 | 0.4475 | 0.4546 | 0.4205 | 0.4446 | 2,055,626 |
| 27/05/26 | 0.458 | 0.4598 | 0.43 | 0.4346 | 2,157,686 |
| 26/05/26 | 0.4892 | 0.4899 | 0.45 | 0.4537 | 943,280 |
| 22/05/26 | 0.489 | 0.4941 | 0.48 | 0.4859 | 363,186 |
|
|
||||
|
|
||||
|
|